Physician profile
Kiumars Arfai
NPI 1407804370
$8,562.91
in general payments reported to CMS, 2019-2025
35 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,188 · 2020: $1,946 · 2021: $1,028 · 2022: $173 · 2023: $904 · 2024: $1,248 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,195 · Education: $33.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,194.90 |
| Education | $33.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,799.97 | 2019-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $1,167.73 | 2019-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $908.13 | 2019-2025 | Intracept |
| Biotronik Nro, INC. | $442.47 | 2024-2025 | Prospera |
| Curonix LLC | $338.70 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $290.75 | 2019-2022 | |
| Nalu Medical, INC. | $242.02 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $159.37 | 2024-2025 | |
| Daiichi Sankyo INC. | $124.17 | 2019 | |
| Biodelivery Sciences International, INC. | $109.30 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.12 | 2019-2025 | Relistor |
| Si-Bone, INC. | $98.04 | 2019 | |
| Stryker Corporation | $87.43 | 2019-2020 | |
| Avanos Medical | $83.25 | 2023-2025 | Genvisc 850 Sodium Hyaluronate, Generator, Trivisc Sodium Hyaluronate |
| Scilex Pharmaceuticals INC. | $77.04 | 2019-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $71.85 | 2025 | Senza |
| Painteq LLC | $55.43 | 2021-2024 | Painteq |
| Depuy Synthes Sales INC. | $44.90 | 2023-2024 | Orthovisc |
| Fidia Pharma USA INC. | $39.09 | 2022-2024 | Triluron, Hyalgan, Hymovis |
| Medtronic USA, INC. | $37.59 | 2020 | |
| Medtronic, INC. | $32.65 | 2021-2023 | Accurian |
| Sentynl Therapeutics, INC. | $26.64 | 2019 | |
| Vertos Medical, INC. | $25.23 | 2024 | Mild Device Kit |
| Assertio Therapeutics, INC. | $21.99 | 2019 | |
| Redhill Biopharma INC. | $21.06 | 2021 | |
| Nevro Corp. | $19.11 | 2022 | |
| Averitas Pharma INC. | $18.63 | 2023 | Qutenza |
| E.R. Squibb & Sons, L.L.C. | $17.98 | 2023 | Camzyos |
| Zyla Life Sciences, INC. | $16.79 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.93 | 2019 | |
| Mdd US Operations, LLC | $14.23 | 2019 | |
| Ibsa Pharma INC. | $13.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.11 | 2019 | |
| Allergan, INC. | $13.10 | 2019 | |
| Forte Bio-Pharma LLC | $7.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiumars Arfai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.